Daniel L. Molin

4.3k citations
87 papers · 3.3k · 3 hit papers · h-index 26

Impact in

Papers in

Daniel L. Molin

84 papers receiving 3.2k citations

Daniel L. Molin's Hit Papers

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial 2024 · 68 citations
680+3+6Years since publication250500750

Peers

Daniel L. Molin
Comparison fields: 5 of 74
  • Pathology and Forensic Medicine 1.7k
  • Oncology 937
  • Immunology 344
  • Genetics 90
  • Radiology, Nuclear Medicine and Imaging 155
Replace Jean Gabarre with:
Jean Gabarre France
Carlos Montalbán Spain
Wing‐Yan Au China
Bettina Fabiani France
María Gomes da Silva Portugal
Josée Audouin France
James A. Strauchen United States
Jeff Wiezorek United States
Meg Elias United States
Jeff S. Aycock United States
Daniel L. Molin relative to Jean Gabarre France Jean Gabarre's profile →
Citations per field
00.5×2×2.8×
Jean Gabarre · 1×
Citations per year

Countries citing papers authored by Daniel L. Molin

Since Specialization
Citations

This map shows the geographic impact of Daniel L. Molin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Molin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Molin more than expected).

Fields of papers citing papers by Daniel L. Molin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Molin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Molin. The network helps show where Daniel L. Molin may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel L. Molin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel L. Molin Line = papers co-authored together Daniel L. Molin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Hit paper breakdown →
2017816
2
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
Hit paper breakdown →
2019271
3 2010171
4 2002151
5 2007139
6 2016135
7 2001111
8 201186
9 201371
10
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
Hit paper breakdown →
202468
11 200765
12 202364
13 200859
14 200358
15 201648
16 202044
17 200543
18 201038
19 200235
20 200731

About Daniel L. Molin

Daniel L. Molin is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Rheumatology, having authored 87 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (66 papers), Viral-associated cancers and disorders (7 papers), Mast cells and histamine (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Medical Image Segmentation Techniques (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and MRI in cancer diagnosis (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.7k citations), Oncology (937 citations), Immunology (344 citations), Genetics (90 citations) and Radiology, Nuclear Medicine and Imaging (155 citations). Daniel L. Molin has collaborated with scholars based in Sweden, Denmark and United States. Frequent co-authors include Gunilla Enblad, Christer Sundström, John A. Radford, Philippe A. Armand, Vincent Ribrag, Ingrid Cecilia Glimelius, Margaret Ann Shipp, Craig H. Moskowitz, Pier Luigi Zinzani and Nathalie A. Johnson. Their work appears in journals such as British Journal of Haematology, Blood, European Journal Of Haematology, Acta Oncologica and Hematological Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact